The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final study analysis of PRINT: Prostate cancer intensive, non–cross-reactive therapy for CRPC.
 
Bobby Chi-Hung Liaw
Consulting or Advisory Role - Exelixis; Sanofi
Speakers' Bureau - Seattle Genetics/Astellas
Research Funding - Bayer; Sanofi
 
Himanshu Joshi
No Relationships to Disclose
 
Tianxiang Sheng
No Relationships to Disclose
 
Che-Kai Tsao
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Guardant Health; Sanofi
Research Funding - Exelixis
 
Matt D. Galsky
Stock and Other Ownership Interests - Rappta Therapeutics
Consulting or Advisory Role - Abbvie; Aileron Therapeutics; Astellas Pharma; AstraZeneca; Basilea; BioMotiv; Bristol-Myers Squibb; Dendreon; Dracen; Dragonfly Therapeutics; EMD Serono; Genentech; Gilead Sciences; GlaxoSmithKline; Incyte; Infinity Pharmaceuticals; Inovio Pharmaceuticals; Janssen; Lilly; Merck; Novartis; NuMab; Pfizer; Seagen; Silverback Therapeutics; Urogen pharma
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792
 
Richard Lorne Bakst
No Relationships to Disclose
 
Robert Stewart
No Relationships to Disclose
 
Richard Stock
No Relationships to Disclose
 
William K. Oh
Employment - Sema4
Leadership - Prostate Cancer Foundation
Stock and Other Ownership Interests - Sema4
Consulting or Advisory Role - Pfizer